Fracaso renal agudo en paciente tratado con antifactor de necrosis tumoral-alfa
Acute renal failure in patient treated with anti-tumour necrosis factor alpha
Leído
18096
Vecesse ha leído el artículo
3099
Total PDF
14997
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 176 | 229 | 405 |
| 2025 5 | 141 | 43 | 184 |
| 2025 4 | 153 | 29 | 182 |
| 2025 3 | 148 | 74 | 222 |
| 2025 2 | 153 | 27 | 180 |
| 2025 1 | 118 | 47 | 165 |
| 2024 12 | 70 | 40 | 110 |
| 2024 11 | 91 | 65 | 156 |
| 2024 10 | 81 | 54 | 135 |
| 2024 9 | 106 | 41 | 147 |
| 2024 8 | 106 | 68 | 174 |
| 2024 7 | 104 | 40 | 144 |
| 2024 6 | 133 | 53 | 186 |
| 2024 5 | 144 | 48 | 192 |
| 2024 4 | 107 | 35 | 142 |
| 2024 3 | 96 | 31 | 127 |
| 2024 2 | 92 | 41 | 133 |
| 2024 1 | 110 | 38 | 148 |
| 2023 12 | 75 | 29 | 104 |
| 2023 11 | 83 | 41 | 124 |
| 2023 10 | 75 | 37 | 112 |
| 2023 9 | 82 | 30 | 112 |
| 2023 8 | 94 | 21 | 115 |
| 2023 7 | 119 | 34 | 153 |
| 2023 6 | 135 | 28 | 163 |
| 2023 5 | 123 | 35 | 158 |
| 2023 4 | 80 | 11 | 91 |
| 2023 3 | 117 | 21 | 138 |
| 2023 2 | 112 | 23 | 135 |
| 2022 1 | 109 | 41 | 150 |
| 2022 12 | 98 | 39 | 137 |
| 2022 11 | 119 | 31 | 150 |
| 2022 10 | 129 | 49 | 178 |
| 2022 9 | 88 | 43 | 131 |
| 2022 8 | 120 | 44 | 164 |
| 2022 7 | 99 | 59 | 158 |
| 2022 6 | 91 | 45 | 136 |
| 2022 5 | 104 | 33 | 137 |
| 2022 4 | 161 | 52 | 213 |
| 2022 3 | 101 | 59 | 160 |
| 2022 2 | 73 | 47 | 120 |
| 2021 1 | 112 | 46 | 158 |
| 2021 12 | 123 | 47 | 170 |
| 2021 11 | 119 | 42 | 161 |
| 2021 10 | 67 | 41 | 108 |
| 2021 9 | 81 | 46 | 127 |
| 2021 8 | 99 | 45 | 144 |
| 2021 7 | 38 | 30 | 68 |
| 2021 6 | 67 | 21 | 88 |
| 2021 5 | 55 | 46 | 101 |
| 2021 4 | 156 | 63 | 219 |
| 2021 3 | 74 | 37 | 111 |
| 2021 2 | 67 | 21 | 88 |
| 2020 1 | 55 | 19 | 74 |
| 2020 12 | 63 | 18 | 81 |
| 2020 11 | 61 | 13 | 74 |
| 2020 10 | 89 | 14 | 103 |
| 2020 9 | 57 | 5 | 62 |
| 2020 8 | 49 | 9 | 58 |
| 2020 7 | 60 | 15 | 75 |
| 2020 6 | 60 | 15 | 75 |
| 2020 5 | 64 | 15 | 79 |
| 2020 4 | 77 | 25 | 102 |
| 2020 3 | 53 | 9 | 62 |
| 2020 2 | 66 | 17 | 83 |
| 2020 1 | 63 | 10 | 73 |
| 2019 12 | 81 | 24 | 105 |
| 2019 11 | 80 | 19 | 99 |
| 2019 10 | 51 | 17 | 68 |
| 2019 9 | 49 | 22 | 71 |
| 2019 8 | 44 | 16 | 60 |
| 2019 7 | 301 | 30 | 331 |
| 2019 6 | 65 | 10 | 75 |
| 2019 5 | 49 | 12 | 61 |
| 2019 4 | 113 | 38 | 151 |
| 2019 3 | 52 | 16 | 68 |
| 2019 2 | 31 | 18 | 49 |
| 2019 1 | 38 | 22 | 60 |
| 2018 12 | 136 | 40 | 176 |
| 2018 11 | 156 | 16 | 172 |
| 2018 10 | 206 | 12 | 218 |
| 2018 9 | 261 | 20 | 281 |
| 2018 8 | 109 | 19 | 128 |
| 2018 7 | 87 | 18 | 105 |
| 2018 6 | 72 | 15 | 87 |
| 2018 5 | 68 | 15 | 83 |
| 2018 4 | 56 | 8 | 64 |
| 2018 3 | 55 | 7 | 62 |
| 2018 2 | 65 | 8 | 73 |
| 2018 1 | 76 | 10 | 86 |
| 2017 12 | 77 | 11 | 88 |
| 2017 11 | 62 | 3 | 65 |
| 2017 10 | 49 | 7 | 56 |
| 2017 9 | 56 | 15 | 71 |
| 2017 8 | 51 | 10 | 61 |
| 2017 7 | 54 | 6 | 60 |
| 2017 6 | 43 | 5 | 48 |
| 2017 5 | 80 | 10 | 90 |
| 2017 4 | 61 | 7 | 68 |
| 2017 3 | 46 | 3 | 49 |
| 2017 2 | 116 | 6 | 122 |
| 2016 1 | 56 | 6 | 62 |
| 2016 12 | 105 | 9 | 114 |
| 2016 11 | 109 | 10 | 119 |
| 2016 10 | 181 | 18 | 199 |
| 2016 9 | 281 | 3 | 284 |
| 2016 8 | 247 | 4 | 251 |
| 2016 7 | 223 | 10 | 233 |
| 2016 6 | 128 | 0 | 128 |
| 2016 5 | 167 | 0 | 167 |
| 2016 4 | 132 | 0 | 132 |
| 2016 3 | 119 | 0 | 119 |
| 2016 2 | 181 | 0 | 181 |
| 2015 1 | 138 | 0 | 138 |
| 2015 12 | 149 | 0 | 149 |
| 2015 11 | 156 | 0 | 156 |
| 2015 10 | 131 | 0 | 131 |
| 2015 9 | 106 | 0 | 106 |
| 2015 8 | 116 | 0 | 116 |
| 2015 7 | 114 | 0 | 114 |
| 2015 6 | 64 | 0 | 64 |
| 2015 5 | 97 | 0 | 97 |
| 2015 4 | 36 | 0 | 36 |
| 2015 2 | 2574 | 0 | 2574 |
Mostrar todo
